Cocrystal Pharma Earnings Estimate

COCP Stock  USD 2.07  0.03  1.43%   
By analyzing Cocrystal Pharma's earnings estimates, investors can diagnose different trends across Cocrystal Pharma's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Cocrystal Pharma is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Cocrystal Pharma is projected to generate -0.49 in earnings per share on the 31st of December 2024. Cocrystal Pharma earnings estimates show analyst consensus about projected Cocrystal Pharma EPS (Earning Per Share). It derives the highest and the lowest estimates based on Cocrystal Pharma's historical volatility. Many public companies, such as Cocrystal Pharma, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Cocrystal Pharma's earnings estimates, investors can diagnose different trends across Cocrystal Pharma's analyst sentiment over time as well as compare current estimates against different timeframes. As of 12/02/2024, Gross Profit Margin is likely to grow to 0.83, though Gross Profit is likely to grow to (14.4 M).
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Cocrystal Pharma Earnings per Share Projection vs Actual

About Cocrystal Pharma Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Cocrystal Pharma earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Cocrystal Pharma estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Cocrystal Pharma fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-315.9 M-300.1 M
Retained Earnings Total Equity-220.4 M-209.4 M
Earnings Yield(1.08)(1.03)
Price Earnings Ratio(0.92)(0.97)
Price Earnings To Growth Ratio 0.02  0.01 

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Cocrystal Stock

  0.65EYEN EyenoviaPairCorr
  0.54ENVB Enveric BiosciencesPairCorr
  0.51A Agilent Technologies Sell-off TrendPairCorr
  0.5FATE Fate Therapeutics TrendingPairCorr
  0.47VRPX Virpax PharmaceuticalsPairCorr
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.